MTOR and plasma cell myeloma: This study highlighted that C96 curtailed PI3K activation and downregulated the activity of mTOR, p70S6K, and 4E-BP1 in both a time- and concentration-dependent manner, culminating in the apoptosis of multiple myeloma cells (27).